Rethinking recruitment strategies for rare disease clinical trials

Rare cardiovascular diseases are on the rise. In fact, there’s a 1 in 10 chance you know someone with a rare disease. Now more than ever, it’s important to throttle the recruitment and retention obstacles in rare disease clinical trials to enable new treatments for this growing patient population.